Docetaxel and 5-FU continuous infusion (DF) versus epirubicin, cisplatin and 5-FU (ECF) for advanced gastric adenocarcinoma; a randomized phase II study

P. Thuss-Patience, Peter Reichardt, A. Vielhaber et al.|European Journal of Cancer|2001

Cited by 2